GUO Shui-long
Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China;Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing 100050, ChinaZHANG Shu-tian
Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China;Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing 100050, ChinaLI Peng
Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China;Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing 100050, China;Beijing Digestive Disease Center, Beijing 100050, ChinaWANG Yong-jun
Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China;Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing 100050, China;Beijing Digestive Disease Center, Beijing 100050, ChinaWANG Min
Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China;Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing 100050, ChinaXING Jie
Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China;Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing 100050, ChinaGUO Qing-dong
Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China;Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing 100050, ChinaSUN Xiu-mei
Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China;Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing 100050, ChinaZHANG Shu-tian
Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China;Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing 100050, China;Beijing Digestive Disease Center, Beijing 100050, ChinaObjective To investigate the regulation role of gastric cancer related miR-148a on gastrin receptor CCKBR expression, and find the correct binding sites of miR-148a in CCKBR 3'UTR. Methods The potential binding sites of miR-148a in the CCKBR 3'UTR were predicted with the bioinformatic tools; The miR-148a expressing plasmid was constructed by PCR, and miR-148a expression was verified by Northern Blot; The luciferase report plasmids containing the wild type and mutated binding sites of CCKBR 3'UTR were constructed, and were used to study the regulation mechanism and identify the binding sites of miR-148a by luciferase activity analysis; The regulation effect of miR-148a on CCKBR protein expression was checked by Western Blot. Results Three potential binding sites of miR-148a in the CCKBR 3'UTR were found; The miR-148a expressing plasmid was constructed successfully, and highly expressed miR-148a after transfected to gastric cancer cells; The inhibitory effect of miR-148a on CCKBR protein expression was checked by Western Blot. Over-expression of miR-148a inhibited CCKBR expression by directly binding to the binding site in CCKBR 3'UTR 423bp. Conclusion CCKBR is a target of miR-148a, and its expression is inhibited by the binding of miR-148a on its 3'UTR, indicating that miR-148a may participates in the progression of gastric cancer by regulating CCKBR expression.
